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Nothing tastes as good as

SKINNY

feels

Unmasking the Neurobiological
Basis of Anorexia

By Louise Yang

F

ood is an unquestionable
need for basic human survival. It is also present at
most social events and celebrations
due to the central role it plays in
bringing people together. Yet for
some people, every single meal
and every single bite is a struggle.
This isolating and life-threatening condition is anorexia nervosa
(AN), a chronic illness characterized by excessively decreased caloric intake, disturbed body image,
and an intense fear of weight gain
(Park et al. 2014). It is a debilitating and heartbreaking disease not
just for the patient but for friends
and family who must watch their
loved one physically waste away
before their very own eyes. The
lack of proper food intake caused
by anorexia deprives the body of
essential proteins and nutrients
that give way to a domino effect
of health issues (Figure 1). This
puzzling, treatment-resistant disease has long been thought of as
Western culture-bound syndrome

140

driven by toxic societal pressures
to diet and be as skinny as possible. How can it be that in countries
with such abundance women are
driven to starving themselves? Why
are some people more susceptible to
this disease? Is it their fault?
The interplay between environment and genetics is essential

for understanding the prevention
and development of anorexia. In
addition, discovering the neurobiological changes made by this
disease are essential for treatment
and grasping why recovery is so
difficult. There is no clear recovery plan for anorexia and current
treatments, such as psychotherapeutic or pharmacological ones
that target abnormal serotonin
systems, have proven inadequate
(Fitzpatrick & Lock, 2011). Researchers are shedding light on the
abnormal brain circuitry displayed
in anorexic patients in hopes of
discovering novel pharmaceuticals and better-targeted treatment
methods for this currently incurable disease.
History of Anorexia
Despite its reputation as a modern
disorder, the first medical report of
anorexia was made in 1689 by London physician Richard Morton.

Figure 1 Diagram of the physical effects of Anorexia Nervosa. http://
www.myedin.org/understanding-anorexia.html
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Figure 2 Meta-analysis of yearly incidences of AN cases in northern Europe. (Makino,
2004)

However, even up to the 1970s,
cases of anorexia were seen as clinical oddities that doctors rarely
saw, let alone knew how to treat
(Arnold, 2016). While rates of
anorexia had been steadily climbing since the 1950s (Figure 2), it
was not until the death of singer
Karen Carpenter in 1983 that anorexia hit mainstream awareness.
The young singer’s death from anorexia-induced organ failure led to
sensationalization of the disease
as the media speculated on why
teenage girls were suddenly “dying
to be thin.” Psychologists blamed
the cause of the disease on a troubled home life and pushy parents,
coupled with unrealistic standards
of beauty propagated by the media and supermodels. Anorexia
was seen as a willful choice made
by selfish young teenage girls who
simply had to choose to get better (Arnold, 2016). The answer
to anorexia is simply to eat, right?
Unfortunately, this backward approach was often recommended
to those who suffer anorexia, to no

avail. However, growing evidence
of the genetic and neurobiological basis behind this debilitating
disease have begun dismantling
these dangerous preconceptions
and brought about a new understanding of the cause and possible
treatment of this currently incurable disease.
Who is affected?
Anorexia affects around 1% of the
population, with 95% of anorexics being females. The average age
of onset is between 14 to 19 years
(Hudson et al., 2007). In addition,
anorexia has the highest mortality
rate among all psychiatric illnesses with one in five deaths being
caused by suicide. Patients with
AN show high comorbidity with
mood disorders such as depression
(35-50%), and around half have
comorbid anxiety disorders including social phobias and obsessive-compulsiveness (Ulfvebrand
et al., 2015). Anorexia is considered a chronic illness because

even though weight restoration is
manageable, relapse is a prevalent
issue (Zanadian et al., 2007). For
example, patients discharged from
the hospital will slowly but surely
return to their old unhealthy eating habits and continue the cycle
of hospitalization.
A study found the following five personality traits increased
the risk of developing an eating
disorder: perfectionism, inflexibility, rule following, excessive
doubt and caution, and a drive for
order and symmetry (Anderluh et
al., 2003). Patients with anorexia also have trouble zooming out
and seeing the big picture and,
instead, get stuck on the little details, which can cause difficulties
with decision making. In addition,
patients with anorexia show difficulty mentally switching from one
task to another (Arnold, 2016).
This strangely similar cluster of
characteristics shared by patients
with anorexia hints at the underlying biological factors behind this
disease because, in addition to predating disease, these traits often
persist after recovery.
Is Anorexia a Western Disorder?
Anorexia has long been thought
of as a western issue that primarily affects white women. Since the
late 20th century there have been
many reports of eating disorders
in Western countries, and few cases had been seen in non-western
countries other than Japan. However, a study in 2004 found that
while the prevalence of anorexia
in non-western countries is lower
than in western countries, it has

141

SCIENTIFIC KENYON

been slowly increasing. Population
and patient-based estimates of AN
in non-western countries ranged
from .002% to 0.7% and was
associated with an increase in abnormal eating attitudes (Makino,
2004). This is, perhaps, an effect
of globalization and the spread of
Western beauty ideals through the
media. For example, before the
1990s there had only ever been
one reported case of anorexia on
the island of Fiji. However, after the introduction of television
to the island in the mid-1990s,
there was a sudden influx of cases.
In addition, in Japan the increase
in anorexia between 1985 and
1992 paralleled modernization.
It is argued that anorexia is more
prevalent during times of cultural change and confusion for immigrants and individuals who are
part of rapidly developing countries (Pke et al., 2015). Even with
this rise in anorexia, the numbers
still remain relatively low in comparison to the general population.
Therefore, the question must be
asked, why are some people more
vulnerable to developing the disease than others? Most people are
exposed daily to unhealthy beauty
ideals, yet never spiral into illness.

ing anorexia, while also contributing to the neurobiological factors
that underlie the disease (Kaye et
al., 2009).
A recent transgenic mouse
model demonstrates the interplay
of genetics, biology, and sociocultural variables that contribute to

the onset of anorexia. Researchers
transgenically created mice with
the BDNF gene, which is a gene
that has been associated with anorexia in humans. Adolescent
mice with the BDNF gene variant placed under environmental
stressors of social stress and on a

The Genetics Behind
Developing AN
While many people diet and express sentiments to lose weight,
only a small percentage actually
develop an eating disorder. This is
due to the highly genetic component of anorexia. Genetic heritability accounts for approximately
50 to 80% of the risk of develop-
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Figure 3 fMRI of the activation of the reward versus the cognitive circuitry of patients
with AN versus controls when hungry versus satiated. (Wierenga et al. 2015)
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calorie-restricted diet were much
more likely than controls to begin
avoiding food (Madra & Zeltser,
2016). This change was not seen
in adult mice, and was also not
induced when mice were subjected to only one stressor and not
the other. This demonstrates that
having an at-risk genotype in itself is not sufficient for developing anorexia-like behavior, but
that disease development is the
combination of stress, dieting,
and age that work together with
a genetic predisposition. This can
help explain the increase in rates
of anorexia in non-western countries due to the introduction of
unhealthy socio-cultural standards
of weight loss and beauty which
then triggers disease development
in youths who are already genetically susceptible. Researchers hope
to use this new mouse model to
study the change and disruptions
in neuronal circuits that cause

Figure 4 fMRI of increased activity in
the left amygdala-hippocampal region,
anterior cingulate, and left insula in the
anorexic group (Ellison et al., 1998).

the metabolic, neuroendocrine,
and behavioral disease symptoms
(Madra & Zeltser, 2016). This
leads to the question, what are the
neuronal disruptions in AN?
Dysregulation of the Reward
System in AN
Many of us resolve to avoid fatty
foods and unhealthy desserts, yet
our self-control often vanishes
when tempted by a piece of cake
after a long day. This normal behavior makes sense considering the
role of hunger as our body’s cue to
seek out and approach food. In
addition, hunger actually increases
the intensity of food rewards, and
this enhanced sensitivity to reward
is a motivational cue to eat, mediated through increased activation
of reward salience circuitry in the
ventral striatum, dorsal caudate,
anterior cingulate cortex (Wierenga et al. 2015). How are patients
with anorexia able to ignore these
urges? Unlike healthy controls,
who show an increased activation
of reward circuitry when hungry,
patients with remitted AN do not
show this increased activation,
lessening their sensitivity to the
motivational drive of hunger (Figure 3).
patients
Furthermore,
with remitted AN showed increased activation in the ventrolateral prefrontal cortex (Figure 3).
This increased activity in cognitive
control circuitry perhaps allows
them to better resist the temptations of food. This can, perhaps,
explain the puzzling question of
how individuals with AN are able
to restrict food intake (Wierenga

et al. 2015). In addition, these differences in activation might possibly occur before the development
of the disorder, demonstrating
the strong biological factors that
predispose certain individuals to
developing AN. Frank (2013) proposed a model of structural and
functional alterations in the insula
and frontal cortex, areas that contribute to both reward and anxiety
processing, that can occur prior to
AN development along with additional changes in these circuits
from malnutrition that can further
hinder recovery by promoting illness behavior and relapse (Frank,
2013).
The neurotransmitter dopamine plays a vital role in regulating the reward system, and alterations in mesolimbic dopamine
levels have been shown in activity-based anorexia mouse models
(Avena & Bocarsly, 2012). Although current dopamine-targeting drug treatments have proven
ineffective in treating the disease,
there is promising research into
atypical antipsychotics that may
modulate the irregular dopamine
systems seen in anorexia (McKnight & Park, 2010).
Abnormal Amygdala
Activation
Patients with AN often display
an abnormal preoccupation with
food-related items, in addition
to a fear of eating high calories
items. Functional magnetic resonance imaging (fMRI) was used
to study the response of patients
with AN when they imagined
drinking high versus low calorie
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Figure 5 AN patients display elevated
global CB1R expression in both cortical
and subcortical regions (Monteleon et al.,
2005).

food. Increased activation in the
limbic and paralimbic network
was associated with high calorie
foods, suggesting a conditioned
fear to high calorie foods (Figure
4). In addition, abnormal activity in the limbic and paralimbic
areas has been associated with
depressive and obsessive-compulsive symptoms, perhaps further
contributing to the prevalence of
these traits in patients with AN
(Ellison et al., 1998). Even after
weight restoration, patients recovering from AN continue to choose
low calorie food over more nutrient dense, higher calorie food
that would help them maintain
a healthy body weight (Berridge,
2003). This calorie fear highlights
how a better understanding of the
neurobiological changes caused by
AN can help the development of
better-targeted strategies to improve existing treatment plans.
Anorexia is also frequently
characterized by a preoccupation
with body size and body dysmorphia, an obsessive focus on
a perceived flaw in appearance.
Concerned parents might look at
their daughter and see an alarmingly skinny body with protruding
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bones, yet the girl herself would
perceive her body as fat. fMRI was
used to study changes in the brain
when patients with AN and controls were stimulated with digital
pictures of their own body image.
In patients with AN, stimulation
with their own body image caused
activation in the right amygdala,
the right gyrus fusiformis, and the
brainstem region (Seeger, 2002).
Studies have linked activation of
the right amygdala to aversive,
anxiety-producing stimulus. Understanding this activation of the
“fear network” in response to one’s
own body can be used to help explain why, during mirror confrontation therapy, patients with AN
display fear and avoidance when
looking at their own body, especially during weight gain (Smeets,
1999). This knowledge can then
possibly be used during recovery
to learn how to combat this conditioned fear of one’s own body.
A Potential New Treatment
Site- the Endocannabinoid

System
The endocannabinoid system is a
new and relatively understudied
potential treatment site for anorexia due to increased information about the critical role it plays
in body homeostasis. CB1-receptors (CB1R) are densely located
in key brain regions involved in
appetite, food intake, and energy
expenditure (Marco et al., 2012).
Studies have shown a deregulation
of the endocannabinoid system in
anorexia. For example, fMRI research has demonstrated that AN
patients display elevated global
CB1R expression in both cortical
and subcortical regions that is believed to be a long-term compensation mechanism for hypofunctioning of the endocannabinoid
system (Figure 5) (Monteleon et
al., 2005). Meanwhile, cannabinoids have been shown to be a safe
and effective tool for treating anorexia associated with weight loss
in patients with AIDS through
activation of CB1 receptors ex-

Figure 6 Dronabinol induced increase in weight gain of AN patients (Andries, 2013)
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pressed in brain regions such as
the hypothalamus and mesocorticolimbic system that are involved
in energy modulation by promoting food intake and reinforcing
the hedonic value of food (Gross,
1983).
Women with severe and
long-lasting anorexia (AN) were
treated with dronabinol, a synthetic cannabinoid agonist, to
study its effects on body weight
and eating disorder related psychopathological personality traits
(Andries, 2013). Participants
gained a significantly greater
amount of weight during dronabinol treatment than during placebo
treatment with no change in leptin
levels. Dronabinol was believed to
facilitate weight gain through an
anabolic mechanism (Figure 6)
(Andries, 2013). This result was
supported by a study on the effects
of CB1R agonist tetrahydrocannabinol (THC) on activity-based
anorexia (ABA) modeling rats.
ABA is the most widely used rodent model used to study the underlying changes in neural circuits
behind anorexia. It models two
key symptoms of anorexia: reduction in food intake and increase
in exercise. Rats that experience
food restriction while having unrestricted access to running wheel
time exhibit hyperactivity by voluntarily spending more time on
the running wheel than those with
unrestricted access to food. These
ABA also exhibit paradoxical reductions in food intake which
leads to weight loss and even death
without experimenter intervention. THC treatment was able to
induce maintenance of a healthy

weight in ABA modeling rats due
to a decrease in energy expenditure
through decreased thermogenesis
(Verty et al., 2011). Studying the
effects of THC on the endocannabinoid system is one step closer to
a promising novel pharmacological treatment for anorexia.
Early detection and Prevention
Early detection is vital for treating
AN because the longer the duration of the disease, the greater the
harmful effects on the body, and
the greater the changes in neural
circuits. A fMRI study showed
that even when recovered from
anorexia, subjects showed irreversible grey matter volume deficits
(Katzman et al., 1997).
Policies can be made to
improve school-based health curricula starting at a younger age,
with content aimed at preventing
eating disorders. In a longitudinal
study, adolescents who engaged in
dieting and unhealthy weight-control behaviors had higher rates of
obesity and eating disorders five
years later. Dieting is a stressor
that can trigger the development
of illness, and parents and schools
should create prevention programs that shift away from drastic
weight-control measures such as
dieting in favor of measures to implement long-term healthful eating and physical activity behaviors
(Neumark et al., 2006). In addition, there needs to be better and
increased training of educators
and health providers with respect
to identifying eating disorders.
Last of all, advertising and
social media policies should be

created to counter the negative
self-image promoted by unrealistic
and unhealthy body ideals on television, print, and social media. For
example, several social media sites
have paved the way by creating
anti-anorexia promoting policies
that have had varying levels of success. It is suggested that the media
can actually be a positive influence
on young, impressionable women
through presenting a greater variety of body shapes and discouragement of dieting.
Conclusion
Overall, the etiology of anorexia is unknown, and much can be
learned from studying the neurobiological basis of the disease. Not
only can current treatment plans
be altered to better fit the needs of
patients in recovery, but promising
new pharmacological drugs may
also better target the abnormal
neural circuitry in AN. Furthermore, understanding the interplay
of genetics and environment in the
development and maintenance of
this disorder can help patients feel
less guilty and isolated when battling this terrible disease.
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